163 related articles for article (PubMed ID: 37517062)
1. An
Roy A; Paul I; Paul T; Hazarika K; Dihidar A; Ray S
J Biomol Struct Dyn; 2024 Aug; 42(12):6136-6164. PubMed ID: 37517062
[TBL] [Abstract][Full Text] [Related]
2. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies.
Mirza SB; Lee RCH; Chu JJH; Salmas RE; Mavromoustakos T; Durdagi S
J Mol Graph Model; 2018 Jan; 79():88-102. PubMed ID: 29156382
[TBL] [Abstract][Full Text] [Related]
3. Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545.
Modhiran N; Gandhi NS; Wimmer N; Cheung S; Stacey K; Young PR; Ferro V; Watterson D
Antiviral Res; 2019 Aug; 168():121-127. PubMed ID: 31085206
[TBL] [Abstract][Full Text] [Related]
4. Phytochemical Compound Screening to Identify Novel Small Molecules against Dengue Virus: A Docking and Dynamics Study.
Shimu MSS; Mahmud S; Tallei TE; Sami SA; Adam AA; Acharjee UK; Paul GK; Emran TB; Zaman S; Uddin MS; Saleh MA; Alshehri S; Ghoneim MM; Alruwali M; Obaidullah AJ; Jui NR; Kim J; Kim B
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163918
[TBL] [Abstract][Full Text] [Related]
5. Identification of neo-andrographolide compound targeting NS1 Lys14: an important residue in NS1 activity driving dengue pathogenesis.
Elumalai E; Suresh Kumar M
J Biomol Struct Dyn; 2023 Jul; 41(10):4504-4514. PubMed ID: 35491708
[TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
[TBL] [Abstract][Full Text] [Related]
7.
Banjan B; Krishnan D; Koshy AJ; Soman S; Leelamma A; Raju R; Revikumar A
J Biomol Struct Dyn; 2024 Jul; 42(11):5963-5981. PubMed ID: 37394810
[TBL] [Abstract][Full Text] [Related]
8. Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study.
Mirza SB; Salmas RE; Fatmi MQ; Durdagi S
J Mol Graph Model; 2016 May; 66():99-107. PubMed ID: 27054972
[TBL] [Abstract][Full Text] [Related]
9. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
10. Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study.
Khan RA; Hossain R; Siyadatpanah A; Al-Khafaji K; Khalipha ABR; Dey D; Asha UH; Biswas P; Saikat ASM; Chenari HA; Wilairatana P; Islam MT
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833913
[TBL] [Abstract][Full Text] [Related]
11. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach.
Qamar MT; Ashfaq UA; Tusleem K; Mumtaz A; Tariq Q; Goheer A; Ahmed B
Pak J Pharm Sci; 2017 Nov; 30(6):2119-2137. PubMed ID: 29175781
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations.
Purohit P; Barik D; Agasti S; Panda M; Meher BR
J Biomol Struct Dyn; 2024 Apr; 42(6):2990-3009. PubMed ID: 37194462
[TBL] [Abstract][Full Text] [Related]
13. [1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation.
Wan YH; Wu WY; Guo SX; He SJ; Tang XD; Wu XY; Nandakumar KS; Zou M; Li L; Chen XG; Liu SW; Yao XG
Acta Pharmacol Sin; 2020 May; 41(5):706-718. PubMed ID: 31729469
[TBL] [Abstract][Full Text] [Related]
14. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus.
Tahir Ul Qamar M; Maryam A; Muneer I; Xing F; Ashfaq UA; Khan FA; Anwar F; Geesi MH; Khalid RR; Rauf SA; Siddiqi AR
Sci Rep; 2019 Feb; 9(1):1433. PubMed ID: 30723263
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations.
Nasir A; Samad A; Ajmal A; Li P; Islam M; Ullah S; Shah M; Bai Q
Int J Biol Macromol; 2024 Jun; 272(Pt 1):132855. PubMed ID: 38834129
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive protein interaction map and druggability investigation prioritized dengue virus NS1 protein as promising therapeutic candidate.
Farooq QUA; Aiman S; Ali Y; Shaukat Z; Ali Y; Khan A; Samad A; Wadood A; Li C
PLoS One; 2023; 18(7):e0287905. PubMed ID: 37498862
[TBL] [Abstract][Full Text] [Related]
17. Peptides targeting dengue viral nonstructural protein 1 inhibit dengue virus production.
Songprakhon P; Thaingtamtanha T; Limjindaporn T; Puttikhunt C; Srisawat C; Luangaram P; Dechtawewat T; Uthaipibull C; Thongsima S; Yenchitsomanus PT; Malasit P; Noisakran S
Sci Rep; 2020 Jul; 10(1):12933. PubMed ID: 32737386
[TBL] [Abstract][Full Text] [Related]
18. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches.
Kaushik S; Dar L; Kaushik S; Yadav JP
J Ethnopharmacol; 2021 Mar; 267():113541. PubMed ID: 33152438
[TBL] [Abstract][Full Text] [Related]
20. In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infections.
Ajmal A; Shahab M; Waqas M; Zheng G; Zulfat M; Bin Jardan YA; Wondmie GF; Bourhia M; Ali I
Sci Rep; 2024 Jun; 14(1):13130. PubMed ID: 38849372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
